The therapeutic potential of angiotensin II receptor blockers in the treatment of heart failure

By McKelvie Robert S  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 3, 2004-03 ,pp. : 245-253

Informa Healthcare

Access to resources Recommend Favorite

The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?

By Karagiannis Asterios   Mikhailidis Dimitri P   Athyros Vasilios G   Kakafika Anna I   Tziomalos Konstantinos   Liberopoulos Evangelos N   Florentin Matilda   Elisaf Moses  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 191-205

Informa Healthcare

Access to resources Recommend Favorite

Economic Benefits of Treating High-Risk Hypertension with Angiotensin II Receptor Antagonists (Blockers)

By Coca Antonio  

Clinical Drug Investigation, Vol. 28, Iss. 4, 2008-01 ,pp. : 211-220

Adis International

Access to resources Recommend Favorite

Comparison of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Essential Hypertension

By Smith David H.G.  

Drugs, Vol. 68, Iss. 9, 2008-01 ,pp. : 1207-1225

Adis International

Access to resources Recommend Favorite

Vascular and metabolic effects of angiotensin II receptor blockers

By Barra Silvia   Vitagliano Alice   Cuomo Vittoria   Vitagliano Giancarlo   Gaeta Giovanni  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 173-189

Informa Healthcare

Access to resources Recommend Favorite